Loading company…
Vitestro develops an autonomous robotic system for collecting blood samples.
Founded in 2017 and based in Utrecht, Netherlands, Vitestro develops Aletta, a robotic phlebotomy device using AI, imaging and robotics. The system is designed for hospitals and clinical laboratories. In March 2026, it raised EUR 60 million in Series B funding from LabCorp Ventures, Mayo Clinic Ventures, MGFO Private Investment, PGGM, Puma Venture Capital, ROM Utrecht Region, Sutter Health, Sonder Capital, European Innovation Council, Invest-NL and NYBC Ventures. The company planned to develop the next-generation device and scale manufacturing and commercial operations.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in